IP Verse

The General Hospital Corporation opposition analysis

COMPANY ANALYSIS

Latest patents of The General Hospital Corporation opposed by its competitors

Patent:
EP2968826
Grant Date:
Jul 17, 2024
Title:
Inspiratory Synthesis Of Nitric Oxide
Oppositions:
1
Patent:
EP2971125
Grant Date:
Nov 22, 2023
Title:
Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
Oppositions:
1
Patent:
EP2906112
Grant Date:
Mar 15, 2023
Title:
System And Method For Monitoring And Controlling A State Of A Patient During And After Administration Of Anesthetic Compound
Oppositions:
1
Patent:
EP3158066
Grant Date:
May 12, 2021
Title:
Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
Oppositions:
1
Patent:
EP3209359
Grant Date:
Jul 1, 2020
Title:
Systems And Methods For The Synthesis Of Nitric Oxide
Oppositions:
1
Patent:
EP2978446
Grant Date:
Mar 4, 2020
Title:
Methods And Agents For Treating Alzheimer'S Disease
Oppositions:
3
Patent:
EP3023788
Grant Date:
Feb 12, 2020
Title:
Compositions Of Tumor Specific Neoantigens
Oppositions:
1
Patent:
EP2349332
Grant Date:
Oct 23, 2019
Title:
Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6
Oppositions:
1
Patent:
EP3066472
Grant Date:
Jul 31, 2019
Title:
Compositions And Methods For Detecting And/Or Treating Inflammation
Oppositions:
1
Patent:
EP2423331
Grant Date:
May 8, 2019
Title:
Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments
Oppositions:
2

Competitors of The General Hospital Corporation

JAMES POOLE LIMITED

BOULT WADE TENNANT LLP

BEYOND AIR, INC.

Want to track The General Hospital Corporation?

Feel free to send us a message here and we will get back to you